Morie Gertz

223PUBLICATIONS
255CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Medical mycologyPredictive and prognostic markersHaematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (223)

|Aug 03, 2026
High prevalence of iron deficiency among daratumumab-treated newly diagnosed multiple myeloma patients.

|Jul 27, 2026
Predictors of post-transplant measurable residual disease negativity and impact on clinical outcomes in multiple myeloma.

|Jul 27, 2026
Self-Reported Geriatric Impairments and Treatment Toxicity in Older Patients with Multiple Myeloma-A Single Center Prospective Study.

|Jul 21, 2026
Cytogenetics-based clinical trajectories in patients with MRD negativity post autologous transplant for multiple myeloma.

|Jul 18, 2026
Combination of daratumumab, ixazomib, and lenalidomide with or without dexamethasone for initial therapy of newly diagnosed myeloma.

|Jun 26, 2026
Early Treatment Failure in Patients Receiving Ciltacabtagene-Autoleucel for Relapsed/Refractory Multiple Myeloma.

Pageof 38

Frequent Collaborators

123 joint publications

Angela Dispenzieri

112 joint publications

Shaji S Kumar

94 joint publications

Taxiarchis V Kourelis

87 joint publications

Eli Muchtar